DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF CLOPAMIDE, DIHYDROERGOCRISTINE MESYLATE AND RESERPINE IN TABLETS

Authors

  • Hussen Al-akraa Dept. of Chemistry, Faculty of Science, Aleppo University
  • Mohamad Kabaweh Dept. of Chemistry, Faculty of Science, Aleppo University

Keywords:

RP-HPLC, Method development, Validation, Clopamide, Dihydroergocristine mesylate, Reserpine

Abstract

Objective: To develop a new, rapid, precise and sensitive RP-HPLC method for the simultaneous determination of Clopamide (CPM), Dihydroergocristine mesylate (DHECM) and Reserpine (RSP) in tablets.

Methods: Caffeine (CAFF) was used as internal standard, a BDS Hypersil column C8 (4.6 x 150 mm) with mobile phase containing a mixture of inorganic phase (ammonium acetate solution in water) and organic phase (acetonitrile and methanol), adjusted with phosphoric acid (10% v/v) to a pH-3.5, the flow rate was 2.0 ml/min, UV detection was performed at a wavelength of 220 nm and injection volume was 20 μl. The validation of this method was done as per ICH guidelines.

Results: Retention times were observed as 1.277, 2.397, 3.799 and 5.202 min for Caffeine, Clopamide, Dihydroergocristine mesylate and Reserpine, respectively. Linearity ranges were observed to be: 1.50-300.00, 2.50-500.00 and 1.00-200.00 μg/ml for Clopamide, Dihydroergocristine mesylate and Reserpine respectively. Relative Standard Deviation did not exceed 2.00%. Detection limits were observed to be 0.08, 0.07 and 0.05 μg/ml for Clopamide, Dihydroergocristine mesylate and Reserpine, respectively.

Conclusion: This method was applied, the first time as simple, rapid, precise and sensitive method for determination of Clopamide, Dihydroergocristine mesylate and Reserpine either alone or in combination, in pure form and in pharmaceutical preparations without interference with any excipient.

 

Downloads

Download data is not yet available.

References

The British Pharmacopoeia 2011;54(4):555-6, 701-3.

Stuber W, Blume H, Sorgel F, Stenzhorn G. Gas-liquid chromatography-mass spectroscopy determination of clopamide in plasma. J Pharm Sci 1989;78(8):679-82.

Panderi I, Parissi-poulou M. Simultaneous determination of clopamide-pindolol combination in tablets by zero-crossing spectrophotometry. J Pharm Biomed Anal 1994;12(2):151-6.

Urszula H, Krzek J, Stankiewicz M. Chromatographic-densitometric method for determination of clopamide and 4-chlorobenzoic, and 4-chloro-3-sulfamoylbenzoic acids in tablets. Curr Pharm Anal 2009;5(8):408-15.

Papadopoulos P, Parissi-poulou M, Panderi I. Development and validation of a reversed-phase HPLC method for determination of pindolol and clopamide in tablets. Jour of LC and R. Tech 2002;25(1):97-101.

Dousa M, Dubovska M. Determination of dihydroergocristine in a pharmaceutical formulation with fluorescence detection. J AOAC Int 2010;93(1):97-01.

Hartman V, Rodiger M, Ableidinger W, Bethke H. Dihydroergotoxine: separation and determination of four components by high-performance liquid chromatography. J Pharm Sci 1978;67(10):98–03.

Bicalho C, Lilla O, Mendes, Gustavo D, Alberto S. Pharmacokinetics of dihydroergocristine and its major metabolite 8'-hydroxy-dihydroergocristine in human plasma. Acad J 2005;6(6):519.

USP 34/NF 29. The United States Pharmacopoeia National Formulary, (29 thedn), Rockville, MD: United States Pharmacopoeial Convention Inc; 2011. p. 4131-2.

Chen H, He Q. Flow injection spectrofluorimetric determination of reserpine in tablets by on-line acetone sensitized photochemical reaction. Pub Med 2000;53(2):463-09.

Settimj G, Di simone L, Del giudice MR. A new gas chromatographic method for the estimation of reserpine and rescinnamine. J Chromatogr 1976;116(2):63-70.

Honigberg I, Stewart J, Smith A, Plunkett R, Hester D. Determination of a reserpine-chlorothiazide mixture. J Pharm Sci 1974;63(11):1762-4.

Hareeshkumar V, Shashidhara S, Anitha S, Rajesh M. Quantitative detection of reserpine in rauwolfia serpentina using HPTLC. Int J Pharm Pharm Sci 2010;2(4):87-9.

Anderson M, Wachs T, Henion J. Quantitative ionspray liquid chromatographic/tandem mass spectrometric determination of reserpine in equine plasma. J Mass Spectrom 1997;2(2):152-8.

Adegoke O, Idowu S, Olanivi A. Improved colorimetric determination of reserpine in tablets using 4-carboxyl-2,6-dintrobenzene diazonium (CDNBD). Trop J Pharm Res 2007;6(2):695-03.

ICH Q2B Validation of Analytical Procedures: Methodology. International conference on Harmonisation, IFPMA, Geneva; 1996.

Miller JC, Miller JN. Statistics for analytical chemistry; 1993;3(3):103-4, 188-90.

Published

01-07-2015

How to Cite

Al-akraa, H., and M. Kabaweh. “DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF CLOPAMIDE, DIHYDROERGOCRISTINE MESYLATE AND RESERPINE IN TABLETS”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 7, July 2015, pp. 148-52, https://www.innovareacademics.in/journals/index.php/ijpps/article/view/4531.

Issue

Section

Original Article(s)